Nuclear HER3 is associated with favorable overall survival in uveal melanoma

International Journal of Cancer

Volumn 130, Issue 5, 2012, Pages 1120-1127

  Trocmé, Eric ^a,b   Mougiakakos, Dimitrios ^a   Johansson, C Christian ^a   All Eriksson, Charlotta ^b   Economou, Mario A ^b   Larsson, Olle ^a   Seregard, Stefan ^b   Kiessling, Rolf ^a   Lin, Yingbo ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

HER3; prognosis; survival; uveal melanoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; UVEA MELANOMA;

AGED; CELL LINE, TUMOR; CELL NUCLEUS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 84155172979     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26118     Document Type: Article

References (44)

1. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM,. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988; 32: 239-51. (Pubitemid 18066234)
2. Singh AD, Bergman L, Seregard S,. Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am 2005; 18: 75-84, viii. (Pubitemid 40348812)
3. Rajpal S, Moore R, Karakousis CP,. Survival in metastatic ocular melanoma. Cancer 1983; 52: 334-6. (Pubitemid 13063179)
4. Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB,. Variates of survival in metastatic uveal melanoma. J Clin Oncol 2005; 23: 8076-80. (Pubitemid 46657410)
5. Hendrix MJ, Seftor EA, Seftor RE, Kirschmann DA, Gardner LM, Boldt HC, Meyer M, Pe'er J, Folberg R,. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF). Am J Pathol 1998; 152: 855-63. (Pubitemid 28173345)
6. Ma D, Niederkorn JY,. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas. Invest Ophthalmol Vis Sci 1998; 39: 1067-75. (Pubitemid 28247340)
7. All-Ericsson C, Girnita L, Seregard S, Bartolazzi A, Jager MJ, Larsson O,. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. Invest Ophthalmol Vis Sci 2002; 43: 1-8. (Pubitemid 34032432)
8. All-Ericsson C, Girnita L, Muller-Brunotte A, Brodin B, Seregard S, Ostman A, Larsson O,. c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target? Invest Ophthalmol Vis Sci 2004; 45: 2075-82. (Pubitemid 38902573)
9. Girnita A, All-Ericsson C, Economou MA, Astrom K, Axelson M, Seregard S, Larsson O, Girnita L,. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Clin Cancer Res 2006; 12: 1383-91. (Pubitemid 43342532)
10. Linggi B, Carpenter G,. ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol 2006; 16: 649-56. (Pubitemid 44809890)
11. Baselga J, Swain SM,. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 2009; 9: 463-75.
12. Koumakpayi IH, Diallo JS, Le Page C, Lessard L, Gleave M, Begin LR, Mes-Masson AM, Saad F,. Expression and nuclear localization of ErbB3 in prostate cancer. Clin Cancer Res 2006; 12: 2730-7.
13. te Velde EA, Franke AC, van Hillegersberg R, Elshof SM, de Weger RW, Borel Rinkes IH, van Diest PJ,. HER-family gene amplification and expression in resected pancreatic cancer. Eur J Surg Oncol 2009; 35: 1098-104.
14. Sithanandam G, Anderson LM,. The ERBB3 receptor in cancer and cancer gene therapy. Cancer Gene Ther 2008; 15: 413-48. (Pubitemid 351822188)
15. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC,. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001; 3: 802-8. (Pubitemid 32842685)
16. Hanada N, Lo HW, Day CP, Pan Y, Nakajima Y, Hung MC,. Co-regulation of B-Myb expression by E2F1 and EGF receptor. Mol Carcinog 2006; 45: 10-7. (Pubitemid 43122365)
17. Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z, Ali-Seyed M, Lee DF, Bartholomeusz G, Ou-Yang F, Giri DK, Hung MC,. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 2004; 6: 251-61. (Pubitemid 39222038)
18. Tao RH, Maruyama IN,. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells. J Cell Sci 2008; 121: 3207-17.
19. Offterdinger M, Schofer C, Weipoltshammer K, Grunt TW,. c-erbB-3: a nuclear protein in mammary epithelial cells. J Cell Biol 2002; 157: 929-39. (Pubitemid 34839768)
20. Zscheppang K, Korenbaum E, Bueter W, Ramadurai SM, Nielsen HC, Dammann CE,. ErbB receptor dimerization, localization, and co-localization in mouse lung type II epithelial cells. Pediatr Pulmonol 2006; 41: 1205-12. (Pubitemid 44893875)
21. Hurks HM, Metzelaar-Blok JA, Barthen ER, Zwinderman AH, De Wolff-Rouendaal D, Keunen JE, Jager MJ,. Expression of epidermal growth factor receptor: risk factor in uveal melanoma. Invest Ophthalmol Vis Sci 2000; 41: 2023-7. (Pubitemid 30450966)
22. Scholes AG, Hagan S, Hiscott P, Damato BE, Grierson I,. Overexpression of epidermal growth factor receptor restricted to macrophages in uveal melanoma. Arch Ophthalmol 2001; 119: 373-7. (Pubitemid 32207259)
23. Mallikarjuna K, Pushparaj V, Biswas J, Krishnakumar S,. Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study. Curr Eye Res 2007; 32: 281-90. (Pubitemid 46439685)
24. Di Cesare S, Nantel A, Marshall JC, Fernandes BF, Antecka E, Orellana ME, Abourbih D, Saornil AM, Burnier MN, Jr., Expression profiling of formalin-fixed paraffin embedded primary human uveal melanomas using DASL matrices. J Cancer Res Clin Oncol 2010; 136: 577-86.
25. Sehat B, Tofigh A, Lin Y, Trocme E, Liljedahl U, Lagergren J, Larsson O,. SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor. Sci Signal 2010; 3: ra10.
26. Folberg R, Kadkol SS, Frenkel S, Valyi-Nagy K, Jager MJ, Pe'er J, Maniotis AJ,. Authenticating cell lines in ophthalmic research laboratories. Invest Ophthalmol Vis Sci 2008; 49: 4697-701.
27. Reschke M, Mihic-Probst D, van der Horst EH, Knyazev P, Wild PJ, Hutterer M, Meyer S, Dummer R, Moch H, Ullrich A,. HER3 is a determinant for poor prognosis in melanoma. Clin Cancer Res 2008; 14: 5188-97.
28. Onken MD, Worley LA, Person E, Char DH, Bowcock AM, Harbour JW,. Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clin Cancer Res 2007; 13: 2923-7. (Pubitemid 46849567)
29. Damato B, Coupland SE,. Translating uveal melanoma cytogenetics into clinical care. Arch Ophthalmol 2009; 127: 423-9.
30. Onken MD, Worley LA, Long MD, Duan S, Council ML, Bowcock AM, Harbour JW,. Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci 2008; 49: 5230-4.
31. Bauer J, Kilic E, Vaarwater J, Bastian BC, Garbe C, de Klein A,. Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer 2009; 101: 813-5.
32. Lake SL, Coupland SE, Taktak AF, Damato BE,. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Invest Ophthalmol Vis Sci 2010; 51: 4884-91.
33. Schoenfield L, Pettay J, Tubbs RR, Singh AD,. Variation of monosomy 3 status within uveal melanoma. Arch Pathol Lab Med 2009; 133: 1219-22.
34. Bonaldi L, Midena E, Filippi B, Tebaldi E, Marcato R, Parrozzani R, Amadori A,. FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas. J Cancer Res Clin Oncol 2008; 134: 1123-7.
35. Horsman DE, Sroka H, Rootman J, White VA,. Monosomy 3 and isochromosome 8q in a uveal melanoma. Cancer Genet Cytogenet 1990; 45: 249-53. (Pubitemid 20129149)
36. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel KH, Becher R,. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996; 347: 1222-5. (Pubitemid 26131850)
37. Aalto Y, Eriksson L, Seregard S, Larsson O, Knuutila S,. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 2001; 42: 313-7. (Pubitemid 32121456)
38. Hernes E, Fossa SD, Berner A, Otnes B, Nesland JM,. Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence. Br J Cancer 2004; 90: 449-54. (Pubitemid 38250644)
39. Kashihara M, Azuma K, Kawahara A, Basaki Y, Hattori S, Yanagawa T, Terazaki Y, Takamori S, Shirouzu K, Aizawa H, Nakano K, Kage M, et al. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer. J Thorac Oncol 2009; 4: 1066-74.
40. Lemoine NR, Lobresco M, Leung H, Barton C, Hughes CM, Prigent SA, Gullick WJ, Kloppel G,. The erbB-3 gene in human pancreatic cancer. J Pathol 1992; 168: 269-73.
41. Friess H, Yamanaka Y, Kobrin MS, Do DA, Buchler MW, Korc M,. Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression. Clin Cancer Res 1995; 1: 1413-20.
42. Esteva FJ, Hortobagyi GN, Sahin AA, Smith TL, Chin DM, Liang SY, Pusztai L, Buzdar AU, Bacus SS,. Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistry. Pathol Oncol Res 2001; 7: 171-7. (Pubitemid 33716851)
43. Tovey SM, Witton CJ, Bartlett JM, Stanton PD, Reeves JR, Cooke TG,. Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling. Breast Cancer Res 2004; 6: R246-51.
44. Olsen DA, Ostergaard B, Bokmand S, Wamberg PA, Jakobsen EH, Jakobsen A, Brandslund I,. HER1-4 protein concentrations in normal breast tissue from breast cancer patients are expressed by the same profile as in the malignant tissue. Clin Chem Lab Med 2009; 47: 977-84.